Bodo Hölzer

437 total citations
8 papers, 100 citations indexed

About

Bodo Hölzer is a scholar working on Infectious Diseases, Surgery and Nephrology. According to data from OpenAlex, Bodo Hölzer has authored 8 papers receiving a total of 100 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 2 papers in Surgery and 2 papers in Nephrology. Recurrent topics in Bodo Hölzer's work include COVID-19 Clinical Research Studies (8 papers), SARS-CoV-2 and COVID-19 Research (5 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (2 papers). Bodo Hölzer is often cited by papers focused on COVID-19 Clinical Research Studies (8 papers), SARS-CoV-2 and COVID-19 Research (5 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (2 papers). Bodo Hölzer collaborates with scholars based in Germany and United States. Bodo Hölzer's co-authors include Timm H. Westhoff, Adrian Doevelaar, Nina Babel, Felix S. Seibert, Frederic Bauer, Benjamin Rohn, Ulrich Budde, Rita Dittmer, Sonja Schneppenheim and Ulf Dittmer and has published in prestigious journals such as Scientific Reports, Critical Care Medicine and Journal of Nephrology.

In The Last Decade

Bodo Hölzer

8 papers receiving 99 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bodo Hölzer Germany 5 78 36 26 14 13 8 100
Parveen Bahel United States 3 77 1.0× 50 1.4× 21 0.8× 8 0.6× 16 1.2× 3 114
Alessia Beccacece Italy 9 99 1.3× 51 1.4× 33 1.3× 5 0.4× 25 1.9× 21 151
Isabel Regalado‐Artamendi Spain 3 73 0.9× 32 0.9× 14 0.5× 3 0.2× 22 1.7× 5 93
Karine Faure France 2 58 0.7× 29 0.8× 9 0.3× 6 0.4× 14 1.1× 3 67
Fadi Kharouf Canada 5 72 0.9× 30 0.8× 29 1.1× 28 2.0× 6 0.5× 35 142
Sarah Warth Germany 4 58 0.7× 18 0.5× 56 2.2× 12 0.9× 22 1.7× 6 144
Myriam Weber Switzerland 4 66 0.8× 21 0.6× 12 0.5× 8 0.6× 2 0.2× 4 109
Ángel Ramírez-Fernández Spain 3 105 1.3× 63 1.8× 21 0.8× 7 0.5× 36 2.8× 5 149
Matthieu Turpin France 5 34 0.4× 13 0.4× 4 0.2× 10 0.7× 14 1.1× 14 85
Milad Gholizadeh Mesgarha Iran 7 52 0.7× 11 0.3× 13 0.5× 42 3.0× 15 1.2× 19 127

Countries citing papers authored by Bodo Hölzer

Since Specialization
Citations

This map shows the geographic impact of Bodo Hölzer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bodo Hölzer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bodo Hölzer more than expected).

Fields of papers citing papers by Bodo Hölzer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bodo Hölzer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bodo Hölzer. The network helps show where Bodo Hölzer may publish in the future.

Co-authorship network of co-authors of Bodo Hölzer

This figure shows the co-authorship network connecting the top 25 collaborators of Bodo Hölzer. A scholar is included among the top collaborators of Bodo Hölzer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bodo Hölzer. Bodo Hölzer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Doevelaar, Adrian, Bodo Hölzer, Felix S. Seibert, et al.. (2023). Generation of potentially inhibitory autoantibodies to ADAMTS13 in coronavirus disease 2019. Scientific Reports. 13(1). 10501–10501. 3 indexed citations
2.
Blazquez‐Navarro, Arturo, Bodo Hölzer, Felix S. Seibert, et al.. (2022). Predictors of impaired SARS-CoV-2 immunity in healthcare workers after vaccination with BNT162b2. Scientific Reports. 12(1). 6243–6243. 3 indexed citations
3.
Pfab, Thiemo, Christian Albert, Sven Schmidt, et al.. (2022). Low‐density lipoprotein apheresis is associated with removal of SARS‐CoV‐2 antibodies. Therapeutic Apheresis and Dialysis. 26(6). 1289–1295. 2 indexed citations
4.
Seibert, Felix S., Arturo Blazquez‐Navarro, Bodo Hölzer, et al.. (2022). Effect of plasma exchange on COVID-19 associated excess of von Willebrand factor and inflammation in critically ill patients. Scientific Reports. 12(1). 4801–4801. 11 indexed citations
5.
Doevelaar, Adrian, Bodo Hölzer, Felix S. Seibert, et al.. (2021). von Willebrand Factor Multimer Formation Contributes to Immunothrombosis in Coronavirus Disease 2019. Critical Care Medicine. 49(5). e512–e520. 41 indexed citations
6.
Doevelaar, Adrian, Bodo Hölzer, Felix S. Seibert, et al.. (2020). Lessons for the clinical nephrologist: recurrence of nephrotic syndrome induced by SARS-CoV-2. Journal of Nephrology. 33(6). 1369–1372. 12 indexed citations
7.
Hölzer, Bodo, Heiner Appel, Nina Babel, et al.. (2020). Impact of renal disease and comorbidities on mortality in hemodialysis patients with COVID-19: a multicenter experience from Germany. Journal of Nephrology. 33(5). 871–874. 19 indexed citations
8.
Thieme, Constantin J., Moritz Anft, Krystallenia Paniskaki, et al.. (2020). The SARS-COV-2 T-Cell Immunity is Directed Against the Spike, Membrane, and Nucleocapsid Protein and Associated with COVID 19 Severity. SSRN Electronic Journal. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026